This is a thumbnail for a blog about navigating the 2026-2027 respiratory virus season.

How to Navigate 2026-2027’s Respiratory Virus Season

If you’re noticing more sniffling and sneezing this time of year, then it can only mean one thing. Seasonal illnesses are making the rounds again, and just in time for the holidays. While the casual reader will be on the lookout for prevention methods… Infection preventionists may have something more to look out for. In an article from Infection Control Today, two experts explained a bit of what this season may have in store.

Today, we’re going to look at ICT’s article talking with the professionals, and see what the experts are saying about this new respiratory virus season. Because the holiday illnesses aren’t something only for infection preventionists, but everybody, whether they’re in healthcare or not. So let’s see how the professionals are helping people navigate this shifting tide of 

What’s in the News?

The holidays are usually marked by more than just the spirit of the season. Respiratory virus season, also commonly referred to as “flu season” kicks in from October all the way to May. As the temperature drops and humidity comes in, the air is a vacation spot for viruses. Specifically, experts are looking at a familiar, yet shifting landscape to navigate. In the article from Infection Control Today, experts Andrew Pekosz, PhD, and Anna Durbin, MD from the Bloomberg School of Public Health talk about the coming months.

This year, there are a few things that everyone’s looking at. First, there’s an unusually early wave of influenza, striking much sooner than usually expected. And the data shows it’s being driven by a mutated H1N1 strain that’s more unknown than not. The other factors are an upcoming rollout of a new mRNA flu vaccine, as well as a delayed, but expected surge of RSV. So let’s look at the specifics to see what the season’s looking like this year.

The Early Flu Wave and the H1N1 Factor

This season, the CDC reported almost 5,000 lab-confirmed hospitalization cases of influenza in the week of October 17th. Expert Anna Durbin said it’s the highest early-season rate for mid October since the 2010-2011 season. This respiratory season introduces the first-ever mRNA vaccine option for influenza.

Andrew Pekosz said that activity is low but increasing in the west and south. And the new H1N1 variant carries new mutations compared with last year’s virus. But the good news is, while some mismatch is expected due to these mutations… CDC data shows that antibodies generated by this season’s current vaccine still recognize the variant. Which means immune escape is only partial.

What to Expect from the New mRNA Flu Vaccine

This respiratory season introduces the first-ever mRNA vaccine option for influenza. Instead of treating the flu like previous vaccines, it uses the same basic technology as the mRNA COVID vaccines. Instead of containing pieces of the virus itself to boost your immune system… It uses messenger RNA (mRNA) and gives your immune system temporary instructions to help it recognize influenza cells to target them. Experts Durbin and Pekosz talked to Infection Control today about the new vaccine, and the information given has two key takeaways.

  • Efficacy & Side Effects: In clinical trials, the mRNA vaccine outperformed traditional vaccines for older adults. However, experts note that recipients may experience slightly more side effects—such as body aches, pains, and low-grade fevers—than they would with conventional shots.
  • Safety Monitoring: Like all vaccines, the new mRNA formulation is subjected to rigorous passive and active safety surveillance. Which include systems like the Vaccine Adverse Event Reporting System, ensuring any adverse events are carefully tracked.

Pekosz added to the talk of this vaccine and said: “Its safety profile is really strong, and it is an option that’s available for people that, at least the preliminary data suggests, could be better in terms of protecting you from severe disease.”

How Can We Protect High-Risk Individuals?

Vulnerable individuals, including older adults, usually 65 and older, and the immunocompromised, remain the primary focus of infection prevention strategies.

  • Protecting the Vulnerable: Many older adults catch respiratory viruses from younger family members—especially grandchildren. Experts emphasize that vaccinating the people surrounding high-risk individuals acts as a protective “shield.”
  • Co-Administration: Flu and COVID-19 vaccines can safely be given at the same time, making it easier for patients to get fully updated in a single visit.

Pekosz also noted an important point; understand the difference between the common cold and influenza. “Trouble breathing suggests infection is moving deeper into the lungs and is probably not a cold,” Pekosz said. Home tests can identify influenza, COVID and respiratory syncytial virus (RSV). Which is important with high-risk patents because flu and COVID antivirals only work if they’re started within a few days of symptom onset. 

Key Takeaways for the Season Ahead

With all of this information given, the question presented now is simple; what are the key takeaways for the upcoming season? Well, here’s a few things that the experts say can help you better navigate the holidays:

  • Review All Eligible Vaccines: This is the ideal window to evaluate protection against all respiratory pathogens (including pneumococcal and COVID-19 boosters) before peak transmission hits.
  • Keep RSV and COVID in Mind: While RSV has been unusually quiet so far, an uptick is expected in the coming weeks. Meanwhile, steady COVID-19 activity points toward a potential surge later in December and January.
  • Early Action Matters: As Dr. Pekosz summarized that getting vaccinated early ensures individuals get the maximum level of protection right before the season peaks.

Final Thoughts

Ultimately, navigating this respiratory season comes down to staying proactive rather than reactive. With an early surge of mutated H1N1 already underway, an anticipated uptick in RSV, and the debut of a new mRNA flu vaccine… Both infection preventionists and everyday individuals have plenty to keep on their radar. The shifting landscape of viral strains and new immunization options might feel overwhelming. But the core strategy remains simple: stay informed, lean on early vaccination to help ensure that the most vulnerable have a better layer of protection. Also, don’t wait until peak season hits to take action. A little preparation now can go a long way toward keeping everyone healthy through the holidays and beyond.

If you’d like to read the full story from Infection Control Today, you can find it here for more. If you have any other questions about infection control products or anything else, give us a call at 704-966-1650 and we’ll help you find what you need!


As always if you have any questions about this process or anything else please feel free to contact us and take advantage of our “FREE TECH SUPPORT.”

We also offer FREE VIRTUAL TECH SUPPORT to “See and Talk” with a “Real Time Live Technician” for any problems you may be in need of help with.

You can also use our “FREE MAINTENANCE PROGRAM”. Take the guesswork and worrying about what unit is due for maintenance and which maintenance cycle it is time for. We will keep track of all your autoclaves and let you know when it’s time for anything.


You can read the full article from Infection Control Today on their site here.

SHOPPING CART

close